Antiviral effects and safety of telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in hepatitis C patients

2008127 citationsJournal Article

Authors

Good health and well-being

Published in: Journal of Hepatology

Volume 49, Issue 2, pp. 163-169

Field-Weighted Citation Impact: 14.23